GOTHENBURG, Sweden, Aug. 3, 2022 /PRNewswire/ — Zinzino group revenue increased with a total of 10%, compared with the previous year.
The revenue in July for Zinzino’s sales markets increased by 10% and amounted to SEK 105.9 (96.6) million. Faun Pharma’s external sales increased by 14% and amounted to SEK 3.3 (2.9) million. Overall, the Group increased revenues by 10% to SEK 109.2 (99.5) million compared with the previous year.
Accumulated revenue for January – July 2022 increased by 2% to SEK 773.1 (755.3) million.
Revenues were distributed as follows:
Countries in regions:
The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA
Asia–Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 14:00 the 3rd of August 2022.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab–publ–preliminary-sales-report-july-2022,c3609831
The following files are available for download: